Understanding the interconnections of microbial pathogenicity phenomena, such as biofilm formation, quorum sensing and antimicrobial resistance, is a tremendous open challenge for biomedical research. Progress made by wetlab researchers and bioinformaticians in understanding the underlying regulatory phenomena has been significant, with converging evidence from multiple high-throughput technologies. Notably, network reconstructions are already of considerable size and quality, tackling both intracellular regulation and signal mediation in microbial infection. Therefore, it stands to reason that in silico investigations would play a more active part in this research. Drug target identification and drug repurposing could take much advantage of the ability to simulate pathogen regulatory systems, host^pathogen interactions and pathogen cross-talking. Here, we review the bioinformatics resources and tools available for the study of the gram-negative bacterium Pseudomonas aeruginosa, the gram-positive bacterium Staphylococcus aureus and the fungal species Candida albicans. The choice of these three microorganisms fits the rationale of the review converging into pathogens of great clinical importance, which thrive in biofilm consortia and manifest growing antimicrobial resistance.
(flagella, pili), production of toxins and proteases, invasion, adhesion to host (e.g. cell, tissues and medical implants), pathogen persistence (e.g. switching from planktonic state to biofilms), formation of polysaccharide capsules and production of molecules for iron uptake (siderophores) and antibiotic resistance (e.g. b-lactamases) [2, 6, 7] . In turn, fungal VFs consist of the secretion of hydrolytic enzymes, morphogenetic conversion (yeast-to-hypha), phenotypic switching, proteinase production, phospholipase activity, hemolytic activity and antifungal resistance (e.g. azoles, echinocandins), among others [8, 9] .
Individual capabilities are augmented by the social skills of the microbes. Typically, microbes communicate and behave as structured social consortia, which provide them significant benefits in terms of host colonization, defence against competitors and adaptation to changing environments (e.g. the contact with antimicrobial treatments). The co-evolution of prokaryotes and eukaryotes has led to the widespread of phenomena such as quorum sensing (QS) cross-talk, biofilm formation and adhesion to host across kingdoms [10] . Indeed, the formation of biofilms, i.e. the formation of microbial communities attached to biotic or abiotic surfaces, and involved with a protective self-produced polymeric matrix, has proven central in developing and sustaining pathogenicity. Biofilm-associated infections are highly resistant to the host immune system and particularly recalcitrant to antimicrobial treatments [11] . In fact, the implications of antimicrobial pressure in the acquisition of drug resistance by microorganisms have become gradually more evident in recent years. Several pathogenic and biofilm-forming strains have acquired resistance to multiple common drugs, leading to the emergence of a new and critical pathogenic phenomenon-the multi-drug resistance [8, 12, 13] .
Also noteworthy, the majority of microbial pathogens are now recognized to thrive in complex biofilm communities, which enhance colonization and augment virulence phenotypes. It is notable the role that polymicrobial biofilms play in chronic and nosocomial infections as clinically relevant as cystic fibrosis, chronic wound infection, endocarditis, catheter-associated urinary tract infection, candidiasis and ventilator-associated pneumonia [14] [15] [16] .
Currently, antimicrobial research is focused on the discovery of new targets for antimicrobial activity [17] [18] [19] , the use of combination agents that are effective against more than one target in the cell [20] , the repurposing of antimicrobial agents [21] and the design of antimicrobial agents with alternative modes of action [22] [23] [24] . Altogether, these efforts are trying to overcome existing virulence and resistance as well as to prevent the development of new pathogenicity determinants. To succeed in these purposes, the complexity of the processes intertwined in virulence and resistance phenomena demands an integrated and systematic study of the machinery of the pathogens, mixed microbial communities and their interactions with the host. Indeed, the function and operation of microbial pathogens have received significant interest with the introduction of highthroughput technologies and Systems Biology methodologies [25] [26] [27] [28] [29] . Now, immunological and microbiological studies focus on representing and interpreting the interaction of pathogenic proteins with host proteins.
In this article, we explore the resources and tools available for the reconstruction of microbial infection mechanisms. Notably, we focus on the regulatory cascades behind QS, biofilm formation and antimicrobial resistance phenomena for three model systems: the gram-negative bacterium Pseudomonas aeruginosa, the gram-positive bacterium Staphylococcus aureus and the fungal species Candida albicans. Often, these species are involved in systemic, chronic and nosocomial infections. They are able to infect a wide range of human tissues, and contaminate medical indwelling devices and clinical settings. Their pathogenicity is associated with a high predisposition to form biofilms (notably polymicrobial biofilms) and the development of antimicrobial resistance mechanisms, which have led to the emergence of multi-drug resistance strains. Therefore, knowledge of the intracellular regulatory circuits of these species, and details on the signals mediating cross-species and cross-kingdom communication, are of vast and critical clinical interest.
This review may be of aid to bioinformaticians who perform in silico modelling and computation in assistance of pathogenicity studies and drug target discovery, and to wet-lab researchers, as it provides an up-to-date and systems-level knowledge representation on relevant bacterial and fungal pathogenicity phenomena.
MICROBIAL PATHOGENICITY: FROM IDENTIFICATION TO FUNCTION
An understanding of pathogen, microbe-microbe and host-pathogen interactions at the molecular level is pivotal to the development of new therapeutic strategies for microbial infection and diseases. It is important to detail the mechanisms of adhesion and signalling involved in infectious interplays, especially at cross-species and cross-kingdom levels, and to clarify the role of different VFs in the interplay. To this end, in silico methods provide support in terms of databases, data mining of large genomes, network analysis, systems biology and structureactivity relationship analysis and similarity analysis [30] [31] [32] .
A number of public resources collect information on pathogens and host-pathogen interactions (see details in Supplementary Table S1 ). Some resources are organism-centric, such as the Pseudomonas Genome Database [33] , and others are topic-centric, such as the Virulence Factors of Pathogenic Bacteria Database (VFDB) [34] , the Antibiotic Resistance Genes Database [35] and the Online Gene Essentiality Database [36] . Furthermore, VFDB [34] supports comparative pathogenomics analyses between several strains of the microorganism, and Staphylococcus aureus Microarray Meta-Database [37] allows comparative analysis between expression datasets.
The reconstruction of networks from the genome sequence of the species is considered useful to identify critical pathways to target for drug development. Genome-scale computational models of metabolism are being used to translate experimental measurements into simulation frameworks [38] [39] [40] . Reverse-engineering approaches support the inference of Transcriptional Regulatory Networks (TRNs) and Protein-Protein Interaction networks (PPIs) [19, [41] [42] [43] [44] [45] [46] . 'Omics' data can be obtained from specialized databases such as Array Express database [47] , and similar databases. Evidences on physical protein and chemical interactions are documented in databases such as STRING [48] and STITCH [49] , and further complemented with text mining, neighbourhood, fusion, occurrence and co-expression data.
The growing interest in the aforementioned issues is emphasized by the number of recent European projects that are conducting systematic studies on antimicrobial resistance, drug target research and host-pathogen interactions. These projects are expected to output a significant number of experimental datasets and present new models and in silico tools. See Supplementary Table S2 for further details.
In the following sections, current understanding of P. aeruginosa, S. aureus and C. albicans pathogenicity phenomena is disclosed and network reconstructions are reviewed.
P. aeruginosa
P. aeruginosa is known for its ability to colonize and persist in acute and chronic infections, mainly in immunocompromised patients. Lung infection is the most relevant niche of P. aeruginosa colonization and it is commonly found in polymicrobial biofilms, associated with S. aureus (e.g. cystic fibrosis) or C. albicans (ventilator-associated pneumonia), which often results in augmented pathogenicity [16] .
Many of P. aeruginosa virulent and resistant phenotypes are under the control of QS systems, but this bacterium also incorporates other forms of regulation, such as the two-component systems, where sensor proteins activate specific transcriptional regulators according to environmental stimuli [20, [126] [127] [128] . Specifically, P. aeruginosa incorporates three QS systems-the two N-acyl-homoserine lactone-mediated signalling systems (las and rhl) and a 2-alkyl-4-quinolone-mediated signalling system [129] -and the two-component regulatory systems PhoP-PhoQ, GacA-GacS, RetS, LadS and AlgR ( Figure 1 -branch A) [130] .
So far, the study of the P. aeruginosa regulatory machinery is mainly described in research articles [127] , and is centred in two strains-the laboratory strain P. aeruginosa PAO1 [131] and the human clinical isolate P. aeruginosa PA14 (Figure 1 -branch B) [132] . Although the list of key regulators is only acquirable by literature curation [133] [134] [135] [136] [137] [138] (Figure 1 [139, 140] .
As a result, P. aeruginosa network reconstructions are already quite detailed, and support various angles of analysis regarding the infection development and drug target discovery. For instance, Galán et al. [141] have reconstructed a TRN ( Figure 1 -branch G) that discloses important pathogenicity phenomena such as alginate biosynthesis, antibiotic resistance and QS. Subsequent topological analysis highlighted the presence of top global regulators related to QS (such as the systems lasR-QS and rhlR-QS) and VF regulation (such as the Vfr regulator and the Fur-ferric uptake regulator).
Other work has depicted P. aeruginosa protein interactome and profiled, to some extent, important proteins in cystic fibrosis disease ( Figure 1 -branch H) [142] . One interaction map describes the action of the anti-sigma factor MucA and the negative regulator MucB, two known players of the alginate regulation and, consequently, of the mucoid phenotype. Another map describes the action of the TF RhIR, which is related to the rhl QS system [142] . Hubness and bottleneck topological analysis, and essentiality information, guided drug target discovery and led to the proposal of 28 new potential drug targets. Later, this work was extended, reconstructing a humanPseudomonas protein interaction network (Figure 1 branch I) that enabled the discovery of three other potential drug targets.
With regard to the study of drug interactions, computational screening has been applied to drug repurposing (i.e. the use of existing drugs for new indications) [21] . Specifically, a drug interaction network ( Figure 1 -branch J) supported the study of raloxifene, a drug that is used in the prevention of osteoporosis and invasive breast cancer in post-menopausal women, and has been predicted to bind to the protein PhzB2, which is involved in production of the QS signalling molecule pyocyanin via phenazine biosynthesis [21] .
Insilico simulations may rely in two models existing for P. aeruginosa PAO1-the models iMO1056 and iMO1086. The model iMO1056 (Figure 1 -branch K) describes the pathways involved in the production of common VFs, such as alginate, rhamnolipids, phenazines and QS molecules [143] . This model was used to investigate enzyme essentiality, compare results with the human metabolic model EHMN [144] and propose a list of 41 potential drug targets [145] . In turn, the model iMO1086 resulted from the comparative analysis of the virulence features of P. aeruginosa and Pseudomonas putida (Figure 1 -branch K) [146] . This analysis revealed marked differences between the two species regarding pathway flexibility for VF production (being higher in P.aeruginosa) [146] . Further details on the aforementioned reconstructions and the associated studies are provided in Supplementary Table S3. S. aureus S. aureus drags research attention as a human pathogen since methicillin-resistant (MRSA) strains were identified, and claimed to be at the cause of severe human diseases, mainly in immunocompromised patients [147] [148] [149] . Now, the emergence of these strains in non-clinical settings, referred to as community-associated MRSA (CA-MRSA), is increasing concern even further [150] .
As a result, and in contrast to P. aeruginosa, studies on S. aureus are not centred on a couple of strains. Studies, as well as data resources, explore many different strains (Figure 2-branch D) and, therefore, data integration and result comparison are not straightforward. Still, the virulence of S. aureus is a welldescribed phenomenon [151] . The regulation of the VFs is intrinsically linked to the agr system (a QS system), which regulates more than 70 genes, 23 of which are known to encode VFs (Figure 2 -branch A) [152] . Databases such as RegPrecise [74] describe the regulatory machinery of S. aureus (Figure 2-branch  D) , and the key regulators have been disclosed (Figure 2-branch B) [153] [154] [155] [156] [157] [158] [159] [160] . Online Gene Essentiality Database catalogues approximately 350 essential genes (Figure 2-branch C) , whereas Antibiotic Resistance Genes Database and VFDB identify major VFs and resistance determinants (Figure 2-branch A) .
Moreover, tools in VFDB support comparative analysis on resistance genes across strains.
Existing reconstructions of S. aureus concentrate on gene essentiality, drug target discovery and the importance of strain variability. Notably, some reconstructions tend to be focused on given pathways or gene functions, and others provide a broader regulatory map as happens in P. aeruginosa.
For instance, a TRN consisting of 16 genes and 38 interactions (Figure 2-branch F) represents the control circuit of the TF Spa, which encodes the VF protein A [161] . This network pinpoints the regulatory importance of XdrA-DNA-binding protein as the major activator of the Spa VF regulon, which is constituted by several members of SarA regulatory protein family (e.g. SarS, Rot and MgrA), the main stress response alternative sigma factor (SigB) and the RNAIII effector molecule of the agr system. The analysis of the interplay of XdrA with the other key Spa regulators revealed a direct influence on Spa rather than via one of its known regulators (namely, SarS, SarA and RNAIII). Ongoing investigation is looking into the role of XdrA regulon in b-lactam resistance.
Another reconstruction focused on strain USA300-FPR3757 (CA-MRSA), which is of increasing clinical interest [162] . A PageRank-based method was used to measure the importance of each player according to its connectivity and, thus, identify potential drug targets. At the top-scoring reactions, there are reactions related to vitamin B and the hem genes, which lead to aberrant colony form Tables S1, S2 and S4 provide further details on these resources).
(namely, small colony variants) known to be associated with pathogenic and drug-resistant phenotypes.
Regarding the variability of virulence and drug resistance among strains, the work of Priest et al. [163] discloses sequence variability across 10 S. aureus strains. The TRN contains the regulators known to affect virulence, revealing an interesting strain-dependent scenario for virulence regulation. The computation of the gene sequences of the 20 most important VFs in the different strains revealed that only the genes sarA and sarR are 100% identical across all strains (Figure 2-branch F) . Complementarily, the model iSB619 genome-scale metabolic model of S. aureus strain N315 was at the base of a metabolic reconstruction based on 13 strains [164] , in which several enzymes essential to growth are proposed as potential drug targets (Figure 2 branch H). Also, the model was compared with the metabolic network of Mycobacterium tuberculosis iNJ661 [165] , using the mixed-integer programming approach CONGA, to identify organism-specific drug targets [87] .
Overton et al. [166] recurred to a Bayesian logistic regression approach to perform the study of S. aureus protein interactions. The approach integrated multiple and heterogeneous information, such as GO annotations, STRING scores, KEGG pathways and data on the species transcriptome and proteome. As a result, a list of 22 novel MRSA VFs is presented (Figure 2 branch G) and the response of the strain MRSA 252 to the antimicrobial peptide ranalexin profiled.
Noteworthy, the DREAM challenge (2010) brought forward one of the first attempts to reconstruct S. aureus general regulation [46] . The inference of simulated and in vivo gene regulation was based on gene condition matrices and putative TFs identified by GO annotation. Further analysis revealed a module of 27 highly enriched pathogenic genes (Figure 2-branch F) , which are involved in exotoxin production (e.g. set7 and set11 genes), biofilm formation (e.g. tacR gene), antibiotic metabolism (e.g. tetR gene) and cell surface proteins (e.g. fnb gene) [46] .
Further details on the aforementioned reconstructions and the associated studies are provided in Supplementary Table S4. C. albicans C. albicans is a commensal and benign organism known to colonize the mucosal membranes in the oral cavity, the gastrointestinal tract, the urogenital mucosa and the vagina [8] . However, certain host conditions may result in its transition to a pathogenic phase [123, 167, 168] . During infection, the fungus manifests a number of VFs, such as the morphological transition between yeast and hyphal forms, the expression of adhesins and invasins on the cell surface, thigmotropism, biofilm formation, phenotypic switching and the secretion of hydrolytic enzymes [118] . In particular, biofilm formation plays a pivotal role in the pathogenicity of C. albicans, as it constitutes a reservoir for the continuum infection, and biofilm cells are much more resistant than planktonic cells to antifungal agents [8] .
Therefore, network reconstructions for C. albicans are mainly related to biofilm formation and hostpathogen interaction, namely, in the strain SC5314 (Figure 3-branch A) [169] . Online databases provide genomic and 'Omics' data ( Figure 3-branch D) , and the literature describes 567 essential genes [170] ( Figure 3 -branch C) and characterizes a number of key players (Figure 3 -branch B) [171] [172] [173] [174] .
Differences between biofilm and planktonic cells have been exposed through a global screening of the TFs potentially related to biofilm formation in C. albicans [175] . This study allowed the reconstruction of two TRNs, one for planktonic cells and another for biofilm communities (Figure 3-branch F) , and the comparison of network interactions in terms of loss and gain-of-function (i.e. interaction detected in the planktonic network but not in the biofilm network and vice-versa). A total of 23 TFs showed differences in function, such that 10 TFs were already known to be involved in biofilm formation, whereas the functional role of other 13 TFs (namely, the TFs Ino4, Rpn4 and Met28) in biofilm formation is still unclear. Recently, the work of Nobile et al. [176] described the master circuit behind the regulation of the TFs Ndt80, Tec1, Brg1, Bcr1, Rob1 and Efg1, validating the function in biofilm formation experimentally (Figure 3-branch F) .
C. albicans adherence regulators, fundamental to the existence of biofilms, have also been characterized [177] . This study summarizes the regulatory relationships among the 30 TFs required for adherence and the 12 TFs that govern the expression of more than one-quarter of the C. albicans cell surface proteins. The resulting network highlights the central role in adherence of the biofilm regulator Bcr1. Also, it exposes the biofilm regulator Ace2 as a major functional target of chromatin remodelling factor Snf5, which in its mutant form generates defects in silicone adherence.
Then, there are studies on host-pathogen interactions. For example, an interspecies TRN (Figure 3 -branch G) is used in a time-resolved analysis of C. albicans and Mus musculus, which discloses phagocytosis by dendritic cells and, in particular, the interaction between the fungal TF Hap3 and the murine pattern recognition receptor Ptx3 [178] . The study proposes a mechanism by which Ptx3 binds to C. albicans leading to cell wall reorganization via Hap3 target genes and thus changing the ability of the fungi to be recognized by immune cells.
The transition from commensalism to systemic infection is another important subject of study. This transition is represented in a TRN (Figure 3 -branch G) [179] , which enabled the identification of the TFs that act predominantly during intestinal colonization (namely, the TFs TYE7, ORF19.3625 and LYS144) and systemic infection (namely, the TFs ZCF21 and LYS14), and some acting in both scenarios (namely, the TFs RTG1/3 and HMS1). From the biological functions identified, cell surface remodelling and the acquisition of carbon and nitrogen sources stand out, evidencing their importance in C. albicans host proliferation.
Intercellular interactions between C. albicans and zebrafish (a model of infectious disease) [180] and how morphology reflects the infectious behaviour on host tissues have also been studied ( Figure 3 branch G) [181] . Based on interactive time profile microarray data of C. albicans and zebrafish during infection, the hyphal growth PPIs, zebrafish PPIs and host-pathogen intercellular PPIs were combined into an integrated infectious PPI network. The integrated PPI network is divided in eight levels according to the location of protein action (i.e. nucleus, intracellular, cell surface or extracellular). At the top, it is the dynamic hyphal PPI network of C. albicans, at the middle the host-pathogen intercellular interaction network and at the bottom the defensive protein interaction network of zebrafish. Results show that hyphal growth, cell wall adhesion and remodelling, biofilm formation, iron homeostasis for C. albicans and apoptosis and innate immune responses in zebrafish are key biological functions in intercellular infection.
Then, there is the study of the regulation of C. albicans iron uptake genes during adhesion and invasion in human oral epithelial cells (Figure 3 branch F) [182, 183] . This study shows that the TFs Rim101, Hap3, Sef1 and Tup1 present a differential expression in experimental infection of human oral epithelial cells. Also, it supported the prediction of four new target genes for Rim101, 11 new target genes for Hap3 and the attribution of the first target gene (FRE7) to Sef1. Moreover, some Tables S1, S2 and S5 provide further details on these resources).
potential new regulations of TFs are proposed, such as Hap3 involvement in the regulation of the gene coding for Rim101 and Tup1.
Further details on the aforementioned reconstructions and associated studies are provided in Supplementary Table S5 .
DISCUSSION
For many years, virulence and antimicrobial resistance phenomena have been studied in depth but individually. Now, it is known that these phenomena are coordinated by intertwining regulatory circuits and certain genes play a key role in more than one phenomenon. In fact, the human-microbial relation has evolved into a scenario of mixed microbial communities capable of forming polymicrobial biofilms. During infection, signalling systems, colonization and defensive strategies are used by microorganisms to share information and thus escape host defences and antimicrobial pressure.
Genome-scale reconstructions enable the systematic study of the interactions within and among pathogens, microbial communities and the human host. Intracellular models, such as TRNs and PPI networks, study the basis of the metabolism and adaptiveness of microbial pathogens, and support the comparison of phenotypes across pathogenic and non-pathogenic strains. Host-pathogen models reflect the host proteome during infection and describe the interplay between the pathogen and the host cells, particularly transitions from commensalism to pathogenic states. Drug-gene interaction models look for potential drug targets and aid in the discovery or repurposing of antimicrobial agents.
The reconstructions described here for P. aeruginosa, S. aureus and C. albicans are the result of the integration of heterogeneous and high-quality data, from public databases and high-throughput experiments. These reconstructions explore different aspects of pathogenicity, being more general or phenomenon-centred depending on the purposes of analysis. Typically, a reduced number of strains of high clinical interest receive most of the attention.
Besides drawing general regulatory pathways, these networks display gene essentiality, virulence and resistance determinants and their interconnections. Biofilm formation and host-pathogen interactions tend to be more attended in studies of fungal pathogenicity. P. aeruginosa studies focus on the discovery of drug targets and drug repurposing applications. While in S. aureus scenario, particular interest is set on studying the development of multi-drug-resistant strains and to this matter, the in silico comparison of phenotypes is considered interesting.
Overall, available resources and tools already offer a considerable ground for analysis of pathogenicity within and across kingdoms. The key to success lies in gathering multi-disciplinary teams that encompass various microbiological knowledge and computer skills and thus are capable of taking the best out of existing resources while generating new insights. Indeed, with some computational support and expert input, network reconstructions can be quite versatile and may be extended, refined or adapted to meet different perspectives of analysis.
Regarding research directions, there are still many open subjects to attend to. Intra-species understanding is far from being consolidated, and infections have often a communitarian and polymicrobial nature that needs to be deciphered. Species and strains reconstructions of pathogenic phenotypes are pivotal to disclose the trigger and the development of a microbial infection. Human models may support the interpretation of host responses to pathogenic cues. Yet, arguably, the reconstruction of microbe-microbe interactions, i.e. the cross-talking that sustains the 'social' functioning of microbial communities, is the next and most promising topic of pathogenicity-related research, much supported by the ever-growing data delivered by metagenomics and metaproteomics studies.
SUPPLEMENTARY DATA
Supplementary data are available online at http:// bib.oxfordjournals.org/.
Key Points
The complexity of pathogenicity phenomena demands for a systematic and integrative approach, preferably entailing in silico investigation. Network reconstructions for key pathogenicity-related phenomena such as biofilm formation, QS, two-component systems and host^pathogen interactions are available. Efforts on the reconstruction of antimicrobial resistance and microbe^microbe cross-talking phenomena are still limited but highly desirable. By combining bioinformatics and wet-lab work, researchers acquire a deeper and systematic understanding about the pathogenicity phenomena, and therefore are in a position of discovering new drug targets and proposing alternative and more effective antimicrobial agents.
